Canakinumab for Treatment of Adult-onset Still's Disease
Status:
Terminated
Trial end date:
2018-05-05
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficacy of the treatment with canakinumab in
participants with Adult-onset Still's Disease (AOSD) and active joint involvement.